The Conquer Cancer Foundation Patient Advocate Scholarship Program

Patient advocates are invited to apply for a scholarship to attend the ASCO Annual Meeting, taking place June 2 to 6 at McCormick Place in Chicago, Illinois.  

Scholarships are intended for expenses related to air or train travel, lodging, and meeting registration for advocates traveling from outside the Chicago area to attend the meeting.  Applications will be evaluated and reviewed based on the Scholarship Eligibility and Criteria

Scholarship recipients based in the United States will be reimbursed $1,800 after the ASCO Annual Meeting and upon receipt of an expense form, applicable receipts, an IRS W-9 form, and a brief testimonial.  Scholarship recipients based outside of the Continental United States will receive $2,200 in U.S. currency during the ASCO Annual Meeting in Chicago.

Applications will be accepted online only, between 12:00 PM (Noon) Eastern Time on Monday, March 6 and 12:00 PM (Noon) Eastern Time on Friday, March 17For your convenience, the application questions are available in advance of the application period. Please read the Scholarship Eligibility and Criteria before submitting a scholarship application. 

All applicants will be notified of their application status by 5:00 PM Eastern Time on Wednesday, March 22.

About the Conquer Cancer Foundation Patient Advocate Scholarship Program

The Conquer Cancer Foundation Patient Advocate Scholarship Program is an opportunity for patient advocates to attend the 2017 ASCO Annual Meeting and then return to their organizations and their communities to share what they have learned.  It is also our hope that scholarship recipients will be motivated to seek out and participate in consumer advocacy opportunities, lending a crucial perspective and making a difference in the lives of people affected by cancer.

This program is made possible by the Conquer Cancer Foundation of the American Society of Clinical Oncology, through the generous support of Astellas; Celgene Corporation; the Conquer Cancer Foundation Mission Endowment; Eisai Inc.; Genentech BioOncology™; Lilly; Patient Access Network Foundation; and Teva Oncology.

For questions about this program, please contact patientadvocates@asco.org.